PRM Pharma and Ingenus Pharmaceuticals Announce Orange Book Listing of Patent Protecting HemiClor® Formulation Technology

Patent ExpiryHemiClorPositive

AI Analysis

Summary

PRM Pharma and Ingenus Pharmaceuticals announced the Orange Book listing of a patent protecting HemiClor formulation technology, providing exclusivity for the chlorthalidone tablet product.

Outcome Details

Orange Book listing of patent protecting HemiClor formulation technology

Importance:2/10

Sentiment:

0.30

PatentOrange BookRegulatoryHemiClorChlorthalidone

Read the original article

Published by PR Newswire Biotech on July 28, 2026 12:00 PM

Read Original